Table 1 Baseline demographics, clinical characteristics, and echocardiographic values
All (n = 55) | No recurrence (n = 36) | Recurrence (n = 19) | P-value | HR | 95% CI | |
|---|---|---|---|---|---|---|
Demographics | ||||||
Age | 61.6 +/− 10.7 | 60.0 +/− 11.6 | 64.9 +/11.6 | 0.104 | 1.02 | 0.99–1.07 |
Males | 44 (80.0%) | 26 (72.2%) | 18 (94.7%) | 0.722 | 0.82 | 0.27–2.48 |
Duration in AF (years) | 3.6 +/− 3.4 | 3.5 +/− 3.5 | 3.4 +/− 3.0 | 0.513 | 1.35 | 0.84–1.53 |
CHA2DS2-VASc Score | 2.0 +/− 1.6 | 1.9 +/− 1.5 | 2.2 +/− 1.7 | 0.89 | 0.98 | 0.73–1.3 |
Comorbidities | ||||||
Hypertension | 32 (58.2%) | 17 (47.2%) | 15 (78.9%) | 0.187 | 1.69 | 0.64–4.46 |
Hyperlipidemia | 26 (47.3%) | 13 (36.1%) | 13 (68.4%) | 0.686 | 1.2 | 0.49–2.97 |
Obstructive sleep apnea | 5 (9.1%) | 2 (5.6%) | 3 (15.8%) | 0.035 | 3.34 | 1.09–10.28 |
Coronary artery disease | 7 (12.7%) | 3 (8.3%) | 4 (21.1%) | 0.745 | 0.81 | 0.24–2.81 |
Cerebrovascular disease | 0 | 0 | 0 | |||
Diabetes mellitus | 6 (10.9%) | 4 (11.1%) | 2 (10.6%) | 0.981 | 1.02 | 0.23–4.42 |
Echocardiographic values | ||||||
Ejection Fraction (%) | 61.8 +/− 5.6 | 61.0 +/− 6.2 | 62.2 +/− 4.3 | 0.506 | 1.03 | 0.94–1.19 |
Mitral regurgitation | 4.01 | 0.93–20.57 | ||||
Mild | 35 (63.6%) | 17 (47.2%) | 17 (89.5%) | 0.056 | ||
Moderate or severe | 0 | 0 | 0 | |||
Tricuspid regurgitation | 1.81 | 0.51–6.46 | ||||
Mild | 30 (54.5%) | 18 (50.0%) | 12 (63.3%) | 0.99 | ||
Moderate | 1 (1.8%) | 0 | 1 (5.3%) | 0.57 | ||
RA dilation | 1.52 | 0.48–4.83 | ||||
Mild | 10 (18.2%) | 5 (9.1%) | 5 (26.3%) | 0.484 | ||
Moderate | 2 (3.6%) | 0 | 2 (10.5%) | 0.180 | ||
LA diameter (cm) | 4.0 +/− 0.6 | 3.9 +/− 0.6 | 4.0 +/− 0.5 | 0.296 | 1.74 | 0.79–5.01 |
LA volume index (cm/m2) | 29.3 +/− 8.0 | 27.4 +/− 5.8 | 31.1 +/− 9.4 | 0.374 | 1.56 | 0.42–5.93 |